{"id":372401,"title":"Canada Gazette Part I – Biologics, Radio-pharmaceuticals & Genetic Therapies - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-11","captureTimestamp":"2026-04-11T16:49:34.603000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/legislation-guidelines/gazette.html","snippet":"Canada Gazette Part I – Biologics, Radio-pharmaceuticals & Genetic Therapies The following proposed regulatory amendments and Regulatory Impact Analysis Statement (RIAS) were recently pre-published in the Canada Gazette Part I for public consultation. Readers are invited to…","rawSnapshotUrl":"/api/snapshots/raw/372401","browseUrl":"https://replay.healtharchive.ca/job-6/20260411164934/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/legislation-guidelines/gazette.html#ha_snapshot=372401","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}